The highly conserved interactions between the MCH and melanocortin pathways in controlling the development and function of melanocytes introduces the possibility that MCH variants might also be risk factors for melanoma, whereby changes in MCH affect POMC/α-MSH signaling. The gene discussed is PMCH; the disease is melanoma.